Pharmafile Logo

Manchester University

Roche - Basel

Roche wins early use RA approval for RoActemra in Europe

Adds to existing indications in arthritis and Castleman’s disease

- PMLiVE

TiGenix appoints Dr Marie Paule Richard

She takes on role as chief medical officer and brings experience from Aicuris and Crucell

- PMLiVE

Has the biological revolution in rheumatoid arthritis peaked?

In the short term the focus looks set to be on personalised use of existing therapies

Fishawack buys UK med comms agency Facilitate

Dealis the Fishawack Group's third in just over a year

Conversis Medical names Mark Hooper global director

He brings 13 years' experience in pharma services to the role

- PMLiVE

Archimed drug safety specialists rebrand

Changes name to Fishawack Archimed following integration

- PMLiVE

GSK to hire doctors as product champions

Will use in-house personnel instead of external speakers to present information

Brand leaders in RA will lose market share, predict rheumatologists

Rheumatologists believe that the current market for biologic treatments in Rheumatoid Arthritis (RA) will see key changes in the next three years.

Research Partnership

Removing the Roadblocks to Effective Patient Treatment

How can pharma benefit from improved patient understanding? Welcome to a new column in which Mary Assimakopoulos, Founding Director of pharma market research specialist the Research Partnership reveals findings from...

Research Partnership

Sanofi reception

Sanofi moves closer to arthritis drug filing

Reports positive late-stage results for sarilumab

Bristol-Myers Squibb (BMS) building

Positive data for BMS’ clazakizumab in arthritis

Phase II results indicate drug is as effective as AbbVie’s Humira

- PMLiVE

Baxter’s Nick Roger joins Bedrock

Takes up role as strategic solutions director at med comms agency

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links